ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly EPS (Basic) of -$1.09 for Q1 2026, up 41.18% year-over-year from -$0.77 in Q1 2025, and up 72.85% quarter-over-quarter from -$4.03 in Q4 2025.
ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported EPS (Basic) for 11 consecutive years, with -$1.09 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 41.18% year-over-year to -$1.09; the TTM figure through Mar 2026 stood at -$6.09 (up 62.06% YoY), while the FY2025 annual figure was -$7.05, up 86.66% from the prior year.
- EPS (Basic) rose to -$1.09 in Q1 2026 per NDRA's latest filing, from -$4.03 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$1.09 in Q1 2026 and bottomed at -$2323.7 in Q1 2022.
- Historically, EPS (Basic) has averaged -$727.56 across 5 years, with a median of -$401.41 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Basic) slipped 4.89% — and 2025, when it soared 99.59%.
- ENDRA Life Sciences' EPS (Basic) stood at -$1991.3 in 2022, then soared by 79.84% to -$401.41 in 2023, then soared by 95.9% to -$16.46 in 2024, then soared by 75.53% to -$4.03 in 2025, then jumped by 72.85% to -$1.09 in 2026.
- Business Quant data shows NDRA's EPS (Basic) at -$1.09 in Q1 2026, -$4.03 in Q4 2025, and -$2.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.77 Bn | 209.71 Bn | 8.34 Bn | 4.74 |
| 2 | Danaher | 139.78 Bn | 135.43 Bn | 3.61 Bn | 1.23 |
| 3 | Idexx Laboratories | 46.04 Bn | 45.85 Bn | 779.09 Mn | 4.29 |
| 4 | Agilent Technologies | 39.68 Bn | 37.88 Bn | 990.00 Mn | 1.20 |
| 5 | Iqvia Holdings | 39.34 Bn | 37.26 Bn | 1.44 Bn | 1.45 |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | -0.60 |
| 7 | Illumina | 29.90 Bn | 28.73 Bn | 770.00 Mn | 1.37 |
| 8 | Mettler Toledo International | 28.58 Bn | 28.53 Bn | 650.22 Mn | 11.57 |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 2.92 |
| 10 | ENDRA Life Sciences | 5.48 Mn | 5.13 Mn | - | -1.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.09 |
| Dec 31, 2025 | -4.03 |
| Sep 30, 2025 | -2.10 |
| Jun 30, 2025 | -1.71 |
| Mar 31, 2025 | -1.86 |
| Dec 31, 2024 | -16.46 |
| Sep 30, 2024 | -9.54 |
| Jun 30, 2024 | -142.99 |
| Mar 31, 2024 | -449.58 |
| Dec 31, 2023 | -401.41 |
| Sep 30, 2023 | -706.18 |
| Jun 30, 2023 | -746.39 |
| Mar 31, 2023 | -1,624.93 |
| Dec 31, 2022 | -1,991.28 |
| Sep 30, 2022 | -1,905.94 |
| Jun 30, 2022 | -2,039.22 |
| Mar 31, 2022 | -2,323.74 |
| Dec 31, 2021 | -2,655.80 |
| Sep 30, 2021 | -2,220.75 |
| Jun 30, 2021 | -2,686.07 |